Abstract:•Dynamic RT-PCR test samples of nasal swabs, blood, fecal, urine, saliva and tears.•Nasal swab had a longer viral shedding time of SARS-CoV-2 than blood and saliva.•Viral shedding time of SARS-CoV-2 in ICU was longer than non-ICU patients. Dear Editor, We read with interest the recent letter by Hao1Hao W. Clinical features of atypical 2019 novel coronavirus pneumonia with an initially negative RT-PCR assay.J Infect. 2020; (PubMed PMID: 32092387. Epub 2020/02/25)Abstract Full Text Full Text PDF PubMed Scopus (22) Google Scholar that addressed the initial negative RT-PCR result in atypical patients. Since outbreak of unexplained pneumonia cases in Wuhan, China in December, 2019,2Zhou P. Yang X.L. Wang X.G. Hu B. Zhang L. Zhang W. et al.A pneumonia outbreak associated with a new coronavirus of probable bat origin.Nature. 2020; (PubMed PMID: 32015507. Epub 2020/02/06)Crossref Scopus (13960) Google Scholar the coronavirus disease 2019 (COVID-19) has spread to more than 90 countries. By 7th March, the infection of SARS-CoV-2 has influenced 101,918 patients globally.3Available from:https://ncov.dxy.cn/ncovh5/view/pneumonia?scene=2&clicktime=1579582186&enterid=1579582186&from=timeline&isappinstalled=0.Google Scholar Recommended by World Health Organization (WHO), 4World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance. [cited 394 10196]. Available from: https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf.Google Scholar a positive real-time reverse transcriptase polymerase chain-reaction (RT-PCR) result could confirm the diagnosis of suspected COVID-19 patients. However, there still lacks thoroughly research concerning viral shedding time among different samples in COVID-19 patients. Here we compared the viral shedding time of SARS-CoV-2 in different samples of intensive care unit (ICU) and non-ICU patients and analyzed their characteristics. We analyzed a total of thirty-two COVID-19 patients admitted to Central Hospital of Xiangtan from January to February, 2020. Dynamic clinical samples including nasal swabs, blood, fecal, urine, saliva and tears were collected from each patient for surveillance. What is more, we recorded synchronous clinical and epidemiologic information with oral consent. Total RNA was extracted from clinical samples and we performed RT-PCR tests targeting SARS-CoV-2. The continuous variants were described by mean when they conform to Kolmogorov-Smirnov test. We did analysis of Chi-square tests and Mann-Whitney tests to compare differences among groups. P < 0.05 was considered significant. Statistical analyses and figures were conducted using the Stata 14 and GraphPad Prism 8. From Table 1, the thirty-two patients include eight ICU and twenty-four non-ICU patients, their age ranged from 34 to 54 years old. A proportion of 43.8% (14/32) patients were from Wuhan and none come back from other cities of Hubei province. Three patients had not been to Hubei province but infected by people from Hubei. Nine of thirty-two patients were identified as family clustered infection. Seven patients had no clear contact history. For the enrolled patients, 40.6% (13/32) of them carried underlying diseases, of which the common diseases were hypertension (5 patients) and diabetes (4 patients). The average onset days was five days and the most common initial symptom was cough (75. 0%, 24/32). Surprisingly, only 53.1% (17/32) patients presented with fever in the beginning. The other symptoms encompassed fatigue, headache, diarrhea, sore throat, muscular soreness and anhelation. Four patients were diagnosed as COVID-19 without symptoms.Table 1Clinical and epidemiologic characteristics of COVID-19 patients.Patients (n = 32)Age-year41(34–54)Male/Female-no.16/16BMI24.5 (22.6–26.5)Epidemic-no. (%)From Hubei provinceWuhan 14(43.8%), other area of Hubei province 0(0.0%)Not been to Hubei province, but infected by people from Hubei province3(9.4%)Without any clear contact history7(21.9%)Family cluster infection9(28.1%)Hospital-related transmission rate (Xiangtan City)0(0.0%)Underlying disease- no. (%)Diabetes4(12.5)Hypertension5(15.6)Cardiovascular diseases1(3.1)Liver disease2(6.3)Malignancy0(0.0)Others1(3.1)Initial symptom-no. (%)Fever17 (53.1)Cough24 (75.0)Fatigue5 (15.6)Headache6 (18.8)Diarrhea3 (9.4)Sore throat7 (21.9)Muscular soreness6 (18.8)Anhelation10 (31.2)No symptoms4 (12.5) Open table in a new tab As indicated by RT-PCR results, we obtained positive rate and viral shedding time of different samples in ICU and non-ICU patients. The positive rate of nasal swab in these patients was 100.0% (32/32) and three patients experienced negative result at the first tests. The positive rate of saliva (78.1%, 25/32) was significantly higher than that of tears (15.6%, 5/32) in enrolled patients (p<0.001). All the urine samples from thirty-two patients were negative. In the tests of blood, the positive rate was 87.5% (7/8) in ICU and 66.7% (16/24) in non-ICU patients respectively. What is more, we performed consecutive analyses of nasal swab, blood and saliva in non-ICU and ICU groups. As shown in Fig. 1(A), the viral shedding (from positive to negative) time of SARS-CoV-2 of nasal swab was significantly longer than that of blood (p = 0.000) and saliva (p = 0.05). Though shorter time of viral shedding in blood samples than saliva was observed, no significant p value was detected (p = 0.070). The viral shedding time of SARS-CoV-2 of nasal swab was 15.67±6.68 days in non-ICU group and 22.25±3.62 days in ICU group. For blood, the viral shedding time was 10.17±6.13 and 14.63±5.88 days in non-ICU and ICU patients respectively. Saliva in non-ICU and ICU patients took 13.33±5.27 and 16.50±6.19 days separately to converse to negative. As shown in Fig. 1(B), the viral shedding time of SARS-CoV-2 of nasal swab in non-ICU patients was significantly shorter than ICU patients (P = 0.02). No obvious significance was indicated in blood and saliva samples between non-ICU and ICU groups. RT-PCR was a widely used tool in diagnosing SARS-CoV-2 infection. Guided by WHO,4World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance. [cited 394 10196]. Available from: https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf.Google Scholar two consecutive negative RT-PCR result with at least two days apart should be achieved before discharge of patients. Several cases have been reported negative of RT-PCR tests before confirmation.1Hao W. Clinical features of atypical 2019 novel coronavirus pneumonia with an initially negative RT-PCR assay.J Infect. 2020; (PubMed PMID: 32092387. Epub 2020/02/25)Abstract Full Text Full Text PDF PubMed Scopus (22) Google Scholar In our study, one patient experienced five continuous negative results before admission and then the sixth nasal swab on admission finally supported his diagnosis. Considering this situation, the molecular diagnosis should be made with other clinical samples or other etiologic tests including serological tests, CRISPR, or metagenomic sequencing. The viral shedding time of SARS-CoV-2 was reported around two weeks.5To K.K. Tsang O.T. Chik-Yan Yip C. Chan K.H. Wu T.C. Chan J.M.C. et al.Consistent detection of 2019 novel coronavirus in saliva.Clin Infect Dis. 2020; (PubMed PMID: 32047895. Epub 2020/02/13)Crossref PubMed Scopus (1212) Google Scholar The longer time consumed to turn from positive to negative in nasal swabs than in blood and saliva samples was in accordance with the respiratory transmission characteristics of the disease, and indicated that a longer surveillance needed in respiratory samples for nucleic acid testing. What is more, in our study, we categorized patients into two groups: ICU and non-ICU. In ICU patients, the viral shedding time of blood, nasal and saliva sample all exceeded two weeks, illustrating a relatively longer period than non-ICU patients. These differences of viral shedding time in ICU and non-ICU patients might be correlated with virus load, severity and invasive operations of patients. In conclusion, our study originally illustrated that nasal swab samples consumed more time to turn negative than blood and saliva samples. What is more, viral shedding time of SARS-CoV-2 in ICU patients was longer than that of non-ICU patients, especially nasal swab samples. A combination tests of different samples might provide us with further information concerning the transmission characteristics of COVID-19 patients. All authors report no potential conflict of interest. We thank the patients for cooperating with our investigation and acknowledge the professionalism and compassion demonstrated by all the healthcare workers involved in patients’ care. This work was supported by National Natural Science Foundation of China [grant number 82041010] and Shanghai Science and Technology Association [grant number 20411950400].

Abstract:Journal of Gastroenterology and HepatologyVolume 35, Issue 10 p. 1836-1838 Letter to the Editor RNA conversion of COVID-19 in respiratory and alimentary specimens during asymptomatic convalescence Yichi Zhang, Yichi Zhang orcid.org/0000-0002-9332-4316 Department of Transplantation, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China These authors contributed equally to this study.Search for more papers by this authorTingting Su, Tingting Su Infectious Disease Department, The Wuxi Fifth Affiliated Hospital of Jiangnan University, Wuxi, China These authors contributed equally to this study.Search for more papers by this authorBing Han, Bing Han Department of Transplantation, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China These authors contributed equally to this study.Search for more papers by this authorMiao Huang, Miao Huang Department of Transplantation, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China These authors contributed equally to this study.Search for more papers by this authorXueshi Zhou, Xueshi Zhou Infectious Disease Department, The Wuxi Fifth Affiliated Hospital of Jiangnan University, Wuxi, ChinaSearch for more papers by this authorJian Wang, Jian Wang Department of Transplantation, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaSearch for more papers by this authorYuanwang Qiu, Yuanwang Qiu [email protected] Infectious Disease Department, The Wuxi Fifth Affiliated Hospital of Jiangnan University, Wuxi, China These authors contributed equally to this study.Search for more papers by this authorYingbin Liu, Yingbin Liu [email protected] orcid.org/0000-0002-1075-1890 Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China These authors contributed equally to this study.Search for more papers by this authorJinyang Gu, Corresponding Author Jinyang Gu [email protected] orcid.org/0000-0003-2727-2420 Department of Transplantation, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China These authors contributed equally to this study. Correspondence Dr Jinyang Gu, Department of Transplantation, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Road, Shanghai 200092, China. Email: [email protected] Dr Yingbin Liu, Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Road, Shanghai 200092, China. Email: [email protected] Dr Yuanwang Qiu, Infectious Disease Department, The Wuxi Fifth Affiliated Hospital of Jiangnan University, Wuxi 214011, China. Email: [email protected]Search for more papers by this author Yichi Zhang, Yichi Zhang orcid.org/0000-0002-9332-4316 Department of Transplantation, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China These authors contributed equally to this study.Search for more papers by this authorTingting Su, Tingting Su Infectious Disease Department, The Wuxi Fifth Affiliated Hospital of Jiangnan University, Wuxi, China These authors contributed equally to this study.Search for more papers by this authorBing Han, Bing Han Department of Transplantation, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China These authors contributed equally to this study.Search for more papers by this authorMiao Huang, Miao Huang Department of Transplantation, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China These authors contributed equally to this study.Search for more papers by this authorXueshi Zhou, Xueshi Zhou Infectious Disease Department, The Wuxi Fifth Affiliated Hospital of Jiangnan University, Wuxi, ChinaSearch for more papers by this authorJian Wang, Jian Wang Department of Transplantation, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaSearch for more papers by this authorYuanwang Qiu, Yuanwang Qiu [email protected] Infectious Disease Department, The Wuxi Fifth Affiliated Hospital of Jiangnan University, Wuxi, China These authors contributed equally to this study.Search for more papers by this authorYingbin Liu, Yingbin Liu [email protected] orcid.org/0000-0002-1075-1890 Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China These authors contributed equally to this study.Search for more papers by this authorJinyang Gu, Corresponding Author Jinyang Gu [email protected] orcid.org/0000-0003-2727-2420 Department of Transplantation, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China These authors contributed equally to this study. Correspondence Dr Jinyang Gu, Department of Transplantation, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Road, Shanghai 200092, China. Email: [email protected] Dr Yingbin Liu, Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Road, Shanghai 200092, China. Email: [email protected] Dr Yuanwang Qiu, Infectious Disease Department, The Wuxi Fifth Affiliated Hospital of Jiangnan University, Wuxi 214011, China. Email: [email protected]Search for more papers by this author First published: 14 May 2020 https://doi.org/10.1111/jgh.15095 Declaration of conflict of interest: None declared. Author contribution: YQ, YL, and JG created the study concept. TS, BH, XZ, and JW performed the data collection. YZ, TS, BH, and MH conducted the data analysis. YZ, BH, and MH wrote the manuscript. YQ, YL, and JG checked the manuscript. All authors approved the final version for publication. Ethical approval: This study was approved by the Ethics Committee of Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (no. XHEC-C-2020-079) and the Wuxi Fifth Affiliated Hospital of Jiangnan University (no. 2020-004-1). Informed consent: Written informed consent was waived. Financial support: This work was supported by grant from the National Natural Science Foundation of China (81772507 to JG). Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Ling Y, Xu SB, Lin YX et al. Persistence and clearance of viral RNA in 2019 novel coronavirus. Chin Med J (Engl) Epub ahead of print 2020; 133(9): 1039–1043. https://doi.org/10.1097/CM9.0000000000000774 10.1097/CM9.0000000000000774 PubMedWeb of Science®Google Scholar 2Zhang W, Du RH, Li B et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect 2020; 9: 386–389. https://doi.org/10.1080/22221751.2020.1729071 10.1080/22221751.2020.1729071 CASPubMedWeb of Science®Google Scholar 3Xie C, Lu J, Wu D, Zhao H, Rao B, Yang Z. False negative rate of COVID-19 is eliminated by using nasal swab test. Travel Med Infect Dis Epub ahead of print 11 Apr 2020. https://doi.org/10.1016/j.tmaid.2020.101668 10.1016/j.tmaid.2020.101668 PubMedWeb of Science®Google Scholar 4Zou L, Ruan F, Huang M. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med 2020; 382: 1177–1179. https://doi.org/10.1056/NEJMc2001737 10.1056/NEJMc2001737 PubMedWeb of Science®Google Scholar 5Liang W, Feng Z, Rao S, Xiao C, Xue X, Lin Z, Zhang Q, Qi W. Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus. Gut Epub ahead of print: 26 Feb 2020. 69(6): 1141-3 doi:https://doi.org/10.1136/gutjnl-2020-320832 10.1136/gutjnl-2020-320832 CASPubMedWeb of Science®Google Scholar 6Song Y, Liu P, Shi XL et al. SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19. Gut Epub ahead of print 5 Mar 2020; 69: 1143–1144. https://doi.org/10.1136/gutjnl-2020-320891 10.1136/gutjnl-2020-320891 CASPubMedWeb of Science®Google Scholar 7Gu J, Han B, Wang J. COVID-19: gastrointestinal manifestations and potential fecal–oral transmission. Gastroenterology Epub ahead of print 3 Mar 2020; 158: 1518–1519. https://doi.org/10.1053/j.gastro.2020.02.054 10.1053/j.gastro.2020.02.054 CASPubMedWeb of Science®Google Scholar 8Xu Y, Li X, Zhu B et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med Epub ahead of print 13 Mar 2020; 26: 502–505. https://doi.org/10.1038/s41591-020-0817-4 10.1038/s41591-020-0817-4 CASPubMedWeb of Science®Google Scholar 9Chen D, Xu W, Lei Z et al. Recurrence of positive SARS-CoV-2 RNA in COVID-19: a case report. Int J Infect Dis Epub ahead of print 2020; 93: 297–299. https://doi.org/10.1016/j.ijid.2020.03.003 10.1016/j.ijid.2020.03.003 CASPubMedWeb of Science®Google Scholar 10Lan L, Xu D, Ye G et al. Positive RT-PCR test results in patients recovered from COVID-19. JAMA Epub ahead of print 27 Feb 2020. https://doi.org/10.1001/jama.2020.2783 10.1001/jama.2020.2783 PubMedWeb of Science®Google Scholar 11Xie C, Jiang L, Huang G et al. Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests. Int J Infect Dis Epub ahead of print 2020; 93: 264–267. https://doi.org/10.1016/j.ijid.2020.02.050 10.1016/j.ijid.2020.02.050 CASPubMedWeb of Science®Google Scholar 12Lipsitch M, Kahn R, Mina MJ. Antibody testing will enhance the power and accuracy of COVID-19-prevention trials. Nat Med Epub ahead of print 27 Apr 2020. https://doi.org/10.1038/s41591-020-0887-3 10.1038/s41591-020-0887-3 Web of Science®Google Scholar Volume35, Issue10October 2020Pages 1836-1838 ReferencesRelatedInformation

SARS-CoV-2 Shedding and Infectivity – Authors' Reply

Prevalence and Persistent Shedding of Fecal SARS-CoV-2 RNA in Patients with COVID-19 Infection: A Systematic Review and Meta-analysis.

Clinical Features in Coronavirus Disease 2019 (COVID-19) Patients with Early Clearance and Prolonged Shedding of Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) RNA.

Clinical Characteristics and Factors Associated with Long-Term Viral Excretion in Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study

Virus Shedding Dynamics in Asymptomatic and Mildly Symptomatic Patients Infected with SARS-CoV-2

Clinical Course and Factors Associated with Viral RNA Shedding and Radiologic Resolution in Patients with COVID-19: a Retrospective Study

Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19)

Characteristics of COVID-19 Patients With SARS-CoV-2 Positivity in Feces

Comparisons of Viral Shedding Time of SARS-CoV-2 of Different Samples in ICU and Non-Icu Patients

Duration of SARS-CoV-2 shedding: A systematic review

RNA Conversion of COVID‐19 in Respiratory and Alimentary Specimens During Asymptomatic Convalescence

Chronological Changes of Viral Shedding in Adult Inpatients with COVID-19 in Wuhan, China.

Clinical course and treatment efficacy of COVID-19 near Hubei Province, China: A multicentre, retrospective study

Duration of Viable Virus Shedding and Polymerase Chain Reaction Positivity of the SARS-CoV-2 Omicron Variant in the Upper Respiratory Tract: a Systematic Review and Meta-Analysis

Prolonged Shedding of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients with COVID-19

Estimating infectiousness throughout SARS-CoV-2 infection course

Prolonged viral shedding of SARS-CoV-2 and related factors in symptomatic COVID-19 patients: a prospective study

Differences of Severe Acute Respiratory Syndrome Coronavirus 2 Shedding Duration in Sputum and Nasopharyngeal Swab Specimens among Adult Inpatients with Coronavirus Disease 2019.

SARS-CoV-2 Viral Dynamic Shedding, Seroconversion, and Diseases Severity among 3192 Patients Hospitalized with COVID-19: A Large Case Series Study in Wuhan

Dynamics of Viral Load and Antibodies in First 8 Weeks of Infection by SARS-CoV-2: an Observational Cohort Study

Population Serology for SARS-CoV-2 is Essential to Regional and Global Preparedness